USPTO 2015–2025 USPTO PatentsView US Corporation

Seventh Sense Biosystems, Inc.

USPTO PatentsView assignee record - 12 granted patents across 7 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Seventh ranks #23,361 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 7 technology areas.

#23,361
of 49,997 US assignees by volume
44th percentile
by Innovation Score (33.2/100)
25.2
avg claims per patent
-50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23361 · US Corporation #23,361 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 12 grants
  • MID-PACK #23,361/49,997
  • PHOTO-FINISH Sensitec
  • CPC-NARROW A61B · 7 areas
  • INNOV-THIN 33.2/100
  • CLAIMS-DENSE 25.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sensitec GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Seventh’s 33.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Seventh

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Seventh's Innovation Score is 33.2/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Seventh?

Each dot is one of Seventh’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Seventh’s own 25.2 claims/patent is ABOVE the 12.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Seventh vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 1015202530 Granted patents (volume) Avg claims / patent Sensitec GmbH - 12, 16.83SensitecSentinel Hydrosolutions, LLC - 12, 12.25Sentinel Hydrosol…Sephora USA, Inc. - 12, 23.25Sephora USASerendipity Technologies LLC - 12, 11.67SerendipityShamrock Seed Company Inc. - 12, 21.83Shamrock SeedShandong Agricultural University - 12, 11Shandong Agricult…Shanghai Fusion Tech Co., Ltd. - 12, 11.17Shanghai Fusion T…Shanghai Universoon Autoparts Co., Ltd. - 12, 12.83Shanghai Universo…Seventh Sense Biosystems, Inc. - 12, 25.17Seventh Sense Bio…
Seventh vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Seventh's grants concentrate

Seventh Sense Biosystems, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 91.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2016. By volume, Seventh sits between Sensitec GmbH and Shanghai Universoon Autoparts Co., Ltd..

Who files at Seventh's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Seventh holds 12 patents at rank #23,426, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Seventh

By rank, the assignees closest to #23,426 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Seventh's primary technology class.

Seventh's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 44th percentile higher than 44% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201520162017201920202021 1
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Seventh Sense Biosystems, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 33.3%
2016 1 8.3%
2017 2 16.7%
2019 1 8.3%
2020 3 25.0%
2021 1 8.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Seventh Sense Biosystems, Inc.'s patent record in context - here's where to go next.

  • Seventh Sense Biosystems, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 91.7% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #23,361 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Seventh Sense Biosystems, Inc. against Sensitec GmbH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.